
Altimmune (ALT) Market Capitalization Overview
Market Cap: $357.45M as of Oct 31, 2025
$357.45M
Past Month+$343.78M (2,515.98%)
As of Oct 31, 2025, Altimmune (ALT) has a market capitalization of $357.45M. Over the past 30 days, its market cap has increased by —, while in the last 12 months, it has increased by —.
Market capitalization represents the total value of Altimmune as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Altimmune (ALT) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Altimmune (ALT) helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Altimmune as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Altimmune (ALT) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Altimmune (ALT) helps investors assess the company's size and compare it with competitors for better investment decisions.
Altimmune (ALT) Market Cap & Key Trends
See Altimmune’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in Altimmune (ALT)
Order type
Buy in
Order amount
Est. shares
0 shares
Altimmune (ALT) Market Cap History
| Date | Market Cap | Change | 
|---|---|---|
| Oct 1, 2025 | $13.46M | — | 
Altimmune (ALT) End of Year Market Cap History
| Date | Market Cap | Change | 
|---|---|---|
| 2025 | $357.45M | — | 
FAQs About Altimmune (ALT) Market Cap
As of Oct 31, 2025, the market capitalization of Altimmune (ALT) is $357.45M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Altimmune’s market capitalization has increased by 2,515.98%, changing from $13.67M to $357.45M as of Oct 31, 2025.
In the last 3 months, Altimmune’s market capitalization has increased by —, changing from – to – as of –.
In the year –, Altimmune’s market capitalization increased from – in January to – in December, reflecting a — change.